Handa Pharmaceuticals, Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 13.253 million compared to TWD 59.036 million a year ago. Operating loss was TWD 153.897 million compared to TWD 74.695 million a year ago. Net loss was TWD 145.403 million compared to TWD 60.000 million a year ago. Basic loss per share was TWD 1.26 compared to TWD 0.57 a year ago.